Is pregabalin considered the standard of care for postoperative pain management after thoracolumbar spine surgery?

Pregabalin is NOT Standard of Care for Thoracolumbar Spine Surgery Pain Management

Pregabalin may be considered as an optional component of multimodal analgesia for thoracolumbar spine surgery, but it is not established as standard of care. The evidence shows mixed results, with some benefit for early postoperative pain reduction but no consistent improvement in opioid consumption or functional outcomes that would justify routine use.

Evidence Assessment

What the Guidelines Actually Say

The available guidelines do not specifically address thoracolumbar spine surgery. The most relevant guideline evidence comes from:

• ICU Pain Management 1: Recommends gabapentinoids (including pregabalin) with opioids specifically for neuropathic pain in critically ill adults (strong recommendation, moderate evidence) and suggests their use after cardiovascular surgery (conditional recommendation, low evidence). This does not translate to routine spine surgery.

• VATS Guidelines 2: For thoracic surgery, pregabalin showed conflicting results. One study found single preoperative dosing reduced 24-hour pain scores without increased side effects 2, while another found no benefit when continued for 5 days 2. A third study showed benefit only for chronic neuropathic pain prevention when continued for 3 months, not acute postoperative pain 2.

• Emergency General Surgery Guidelines 3: State gabapentinoids "can be considered" as part of multimodal analgesia (moderate recommendation, moderate evidence), but emphasize they should be limited to single lowest preoperative dose due to sedation and other adverse effects 4.

Spine Surgery-Specific Research Evidence

The research specific to lumbar spine surgery reveals important limitations:

Most Recent High-Quality Study 5 (2026): A double-blind RCT of 54 patients undergoing laminectomy and fusion found:

• No difference in 48-hour morphine consumption (primary outcome)
• Only a single time point (24 hours) showed statistically significant pain reduction
• No difference in opioid-related side effects
• Conclusion: Pregabalin did not significantly alter opioid consumption

Systematic Review 6 (2025): Meta-analysis of gabapentinoids in lumbar surgery found:

• No significant differences in 24-hour VAS pain scores between pregabalin, gabapentin, or placebo
• No significant difference in 24-hour morphine requirement for pregabalin versus placebo
• Conclusion: "Definitive conclusions regarding efficacy remain limited"

Older Studies Show Conflicting Results:

• One 2012 study 7 showed reduced early pain and 3-month quality of life improvement
• A 2014 study 8 found pregabalin improved 3-month functional outcomes
• A 2018 study 9 showed pregabalin superior to gabapentin for postoperative analgesia

Clinical Algorithm for Decision-Making

When to Consider Pregabalin:

1. Patient has pre-existing neuropathic pain component (radiculopathy, chronic nerve pain)

   • Single preoperative dose: 150 mg, 1-2 hours before surgery
   • Consider continuation only if neuropathic pain persists postoperatively

2. Patient is opioid-tolerant or at high risk for inadequate pain control

   • Use as part of multimodal regimen, not monotherapy
   • Limit to lowest effective dose (75-150 mg)

3. Adjust for renal function and age:

   • Elderly patients: Use with caution, increased sedation risk
   • CrCl 30-60 mL/min: Reduce dose by 50%
   • CrCl <30 mL/min: Consider alternative

When NOT to Use Pregabalin:

• Routine, uncomplicated thoracolumbar surgery without neuropathic component
• Elderly patients with fall risk or cognitive impairment
• When sedation would compromise early mobilization
• As monotherapy for postoperative pain

Standard of Care Recommendation

The actual standard of care for thoracolumbar spine surgery pain management consists of 3:

1. Acetaminophen (1g IV/PO every 6 hours) - start preoperatively
2. NSAIDs or COX-2 inhibitors (if no contraindications) - preoperative and scheduled postoperatively
3. Opioids as rescue analgesia with lowest effective dose
4. Regional techniques when appropriate (local infiltration, epidural for extensive procedures)

Critical Caveats

• Sedation risk: Pregabalin causes dose-dependent sedation, dizziness, and visual disturbances that may interfere with early mobilization—a key component of enhanced recovery after spine surgery 4

• No long-term benefit established: The 2026 RCT 5 and 2025 meta-analysis 6 represent the highest quality recent evidence and show no consistent benefit for the outcomes that matter most (opioid consumption, functional recovery)

• Publication bias concern: Older positive studies may reflect selective reporting; more recent rigorous trials show null results

• Cost-effectiveness not established: Without clear benefit in opioid reduction or functional outcomes, routine use cannot be justified

Bottom line: Pregabalin remains an optional adjunct for selected patients with neuropathic pain components, not a standard component of routine thoracolumbar spine surgery analgesia protocols.